Neoadjuvant zoledronic acid for HER2-positive breast cancer: the Zo-NAnTax trial by Susanne Crocamo, Renata Binato, Bruno de Paula, Giselle Vignal, Lídia Magalhães, Roberta Sarmento, Maria Theresa Accioly, Isabele Small, Sandra Gioia, Pedro Maroun, Pamela Moutinho, Vivianne Freitas, Karuline Catein, Eliana Abdelhay

Get full text